Jubilant Ingrevia (India) Financials

Understanding current and past Jubilant Ingrevia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Jubilant Ingrevia's financial statements are interrelated, with each one affecting the others. For example, an increase in Jubilant Ingrevia's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Jubilant Ingrevia's financials over time to get the whole picture.
We strongly advise to harness Jubilant Ingrevia fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Jubilant Ingrevia is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to collect and analyze data for twenty-six available reported financial drivers for Jubilant Ingrevia, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Jubilant Ingrevia financials, including its shares outstanding, cash and equivalents, number of employees, as well as the relationship between the revenue and current ratio .

Jubilant Fundamentals 

With this module, you can analyze Jubilant financials for your investing period. You should be able to track the changes in Jubilant Ingrevia individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Chance Of Financial Distress
Less than 26
Jubilant Ingrevia Limited has less than 26 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Jubilant Ingrevia stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Jubilant Ingrevia's official financial statements usually reflect Jubilant Ingrevia's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Jubilant Ingrevia. For example, before you start analyzing numbers published by Jubilant accountants, it's critical to develop an understanding of what Jubilant Ingrevia's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Jubilant Ingrevia's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Jubilant Ingrevia's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Jubilant Ingrevia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Jubilant Ingrevia Limited. Please utilize our Beneish M Score to check the likelihood of Jubilant Ingrevia's management to manipulate its earnings.

Jubilant Ingrevia Company Summary

Jubilant Ingrevia Limited provides life science products and solutions in India and internationally. Jubilant Ingrevia Limited was incorporated in 2019 and based in Noida, India. Jubilant Ingrevia operates under Biotechnology classification in India and is traded on National Stock Exchange of India. It employs 2100 people.
InstrumentIndia Stock View All
ExchangeNational Stock Exchange of India
Business Address1A, Sector 16A
Phone91 12 0436 1000
You should never invest in Jubilant Ingrevia without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Jubilant Stock, because this is throwing your money away. Analyzing the key information contained in Jubilant Ingrevia's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Jubilant Ingrevia Key Financial Ratios

Generally speaking, Jubilant Ingrevia's financial ratios allow both analysts and investors to convert raw data from Jubilant Ingrevia's financial statements into concise, actionable information that can be used to evaluate the performance of Jubilant Ingrevia over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Jubilant Ingrevia reports annually and quarterly.

Jubilant Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Jubilant Ingrevia's current stock value. Our valuation model uses many indicators to compare Jubilant Ingrevia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Jubilant Ingrevia competition to find correlations between indicators driving Jubilant Ingrevia's intrinsic value. More Info.
Jubilant Ingrevia Limited is currently regarded as number one stock in profit margin category among related companies. It is currently regarded as number one stock in market capitalization category among related companies creating about  13,443,609,023  of Market Capitalization per Profit Margin. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Jubilant Ingrevia by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Jubilant Ingrevia's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Jubilant Ingrevia's earnings, one of the primary drivers of an investment's value.

Jubilant Ingrevia Thematic Clasifications

Jubilant Ingrevia Limited is part of Healthcare investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Healthcare industry as classified by Fama & French. Fama and French focuses on testing asset pricing under different economic assumptions
Healthcare Idea
This theme covers USA Equities from Healthcare industry as classified by Fama & French. Fama and French focuses on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Risk vs Return Analysis. Note that the Jubilant Ingrevia information on this page should be used as a complementary analysis to other Jubilant Ingrevia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Transaction History module to view history of all your transactions and understand their impact on performance.

Other Tools for Jubilant Stock

When running Jubilant Ingrevia price analysis, check to measure Jubilant Ingrevia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jubilant Ingrevia is operating at the current time. Most of Jubilant Ingrevia's value examination focuses on studying past and present price action to predict the probability of Jubilant Ingrevia's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Jubilant Ingrevia's price. Additionally, you may evaluate how the addition of Jubilant Ingrevia to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
CEO Directory
Screen CEOs from public companies around the world
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Transaction History
View history of all your transactions and understand their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.